JP2004504403A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004504403A5 JP2004504403A5 JP2002514148A JP2002514148A JP2004504403A5 JP 2004504403 A5 JP2004504403 A5 JP 2004504403A5 JP 2002514148 A JP2002514148 A JP 2002514148A JP 2002514148 A JP2002514148 A JP 2002514148A JP 2004504403 A5 JP2004504403 A5 JP 2004504403A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- temperature
- room temperature
- oxidation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims description 18
- 150000001875 compounds Chemical class 0.000 claims description 7
- 238000007254 oxidation reaction Methods 0.000 claims description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- 230000003647 oxidation Effects 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 239000012296 anti-solvent Substances 0.000 claims description 3
- 230000001590 oxidative effect Effects 0.000 claims description 3
- 230000001376 precipitating effect Effects 0.000 claims description 3
- 239000011541 reaction mixture Substances 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 239000013078 crystal Substances 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 239000007800 oxidant agent Substances 0.000 claims 4
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical group OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 claims 3
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims 2
- QFWPJPIVLCBXFJ-UHFFFAOYSA-N glymidine Chemical compound N1=CC(OCCOC)=CN=C1NS(=O)(=O)C1=CC=CC=C1 QFWPJPIVLCBXFJ-UHFFFAOYSA-N 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0017988.7A GB0017988D0 (en) | 2000-07-21 | 2000-07-21 | Novel process |
| PCT/GB2001/003289 WO2002008243A1 (en) | 2000-07-21 | 2001-07-20 | Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004504403A JP2004504403A (ja) | 2004-02-12 |
| JP2004504403A5 true JP2004504403A5 (enExample) | 2008-09-04 |
Family
ID=9896132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002514148A Pending JP2004504403A (ja) | 2000-07-21 | 2001-07-20 | 中間体６α，９α−ジフルオロ−１１β，１７α−ジヒドロキシ−１６α−メチル−アンドロスタ−１，４−ジエン−３−オン−１７β−カルボン酸の製造のための酸化方法 |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US20040043974A1 (enExample) |
| EP (1) | EP1301526B1 (enExample) |
| JP (1) | JP2004504403A (enExample) |
| KR (1) | KR100787293B1 (enExample) |
| CN (1) | CN1315864C (enExample) |
| AT (1) | ATE398628T1 (enExample) |
| AU (2) | AU2001270906B2 (enExample) |
| BR (1) | BR0110430A (enExample) |
| CA (1) | CA2406963A1 (enExample) |
| CY (1) | CY1108553T1 (enExample) |
| CZ (1) | CZ302592B6 (enExample) |
| DE (1) | DE60134472D1 (enExample) |
| DK (1) | DK1301526T3 (enExample) |
| ES (1) | ES2307628T3 (enExample) |
| GB (1) | GB0017988D0 (enExample) |
| HK (1) | HK1056179B (enExample) |
| HU (1) | HUP0301108A3 (enExample) |
| IL (2) | IL152348A0 (enExample) |
| MX (1) | MXPA02010967A (enExample) |
| NO (1) | NO324836B1 (enExample) |
| NZ (1) | NZ522083A (enExample) |
| PL (1) | PL206652B1 (enExample) |
| PT (1) | PT1301526E (enExample) |
| SI (1) | SI1301526T1 (enExample) |
| WO (1) | WO2002008243A1 (enExample) |
| ZA (1) | ZA200208372B (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
| US6787532B2 (en) | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
| US6858593B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| US6759398B2 (en) | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
| US6777400B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| CO5310534A1 (es) | 2000-08-05 | 2003-08-29 | Glaxo Group Ltd | Nuevos derivados de androstano anti-inflamatorios |
| US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
| US6750210B2 (en) | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
| UA77656C2 (en) | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
| ES2314052T3 (es) | 2001-04-30 | 2009-03-16 | Glaxo Group Limited | Derivados de ester de 17beta-carbotioato de androstano con un grupo ester ciclico en la posicion 17alfa. |
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| IL150654A (en) | 2002-07-09 | 2006-12-10 | Ori Lerman | Method for acid isolation 6α, 9α - difluoro - ß, 17α11 - dihydroxy - 16α - methylfargana - 3 - oxo - 1, 4 - diene - 17ß - carboxylate |
| JP2006522028A (ja) * | 2003-04-04 | 2006-09-28 | アルファーマ エーピーエス | ステロイド性カルボチオ酸誘導体の製造方法および中間体 |
| EP1466920A1 (en) * | 2003-04-04 | 2004-10-13 | Alpharma APS | Process for the preparation of steroidal 17 beta-carbothioates |
| EP1526139A1 (en) * | 2003-10-24 | 2005-04-27 | S.N.I.F.F. Italia S.P.A. | A process for preparing highly pure androstane 17-beta-carboxylic acids and androstane 17-beta-carbothioic acid fluoromethyl esters |
| GB0612027D0 (en) | 2006-06-16 | 2006-07-26 | Glaxo Group Ltd | Novel process |
| NO331891B1 (no) | 2007-03-20 | 2012-04-30 | Clavis Pharma Asa | Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS |
| PT105139B (pt) * | 2010-06-01 | 2013-01-29 | Hovione Farmaciencia S A | Método para a monofluorometilação de substratos orgânicos para preparação de compostos orgânicos biologicamente activos |
| WO2012029077A2 (en) | 2010-09-01 | 2012-03-08 | Cadila Healthcare Limited | Process for preparing fluticasone propionate/furoate |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3636010A (en) * | 1968-12-23 | 1972-01-18 | Ciba Geigy Corp | Esters of steroid-17-carboxylic acids |
| NL187577C (nl) * | 1978-04-05 | 1991-11-18 | Sibla Srl | 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen. |
| US4188385A (en) * | 1978-04-05 | 1980-02-12 | Syntex (U.S.A.) Inc. | Thioetianic acid derivatives |
| US4198336A (en) * | 1978-04-05 | 1980-04-15 | Syntex (U.S.A.) Inc. | Chemical process for preparing androsta-4-ene 17α-carboxylic acids |
| US4263289A (en) * | 1978-04-05 | 1981-04-21 | Syntex (U.S.A.) Inc. | Thio etianic acid derivatives |
| GB2088877B (en) * | 1980-02-15 | 1984-07-04 | Glaxo Group Ltd | Androstane 17 carbothioates |
| US5646136A (en) * | 1994-01-04 | 1997-07-08 | Duke University | Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids |
| US6197761B1 (en) * | 1995-12-29 | 2001-03-06 | Glaxo Wellcome Inc. | 17β-2-oxo-tetrahydrofuranyl)-carbothioic acid ester, -carboxylic acid ester and -carboxylic acid amide androstane derivatives |
| US20020133032A1 (en) * | 2000-02-25 | 2002-09-19 | Jufang Barkalow | Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods |
| MXPA02009814A (es) * | 2000-04-04 | 2003-03-27 | Celanese Int Corp | Composiciones de revestimiento receptivas de tinta que contienen alcohol polivinilico injertado con grupos funcionales amina. |
| US6777400B2 (en) * | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
-
2000
- 2000-07-21 GB GBGB0017988.7A patent/GB0017988D0/en not_active Ceased
-
2001
- 2001-07-20 WO PCT/GB2001/003289 patent/WO2002008243A1/en not_active Ceased
- 2001-07-20 PT PT01949791T patent/PT1301526E/pt unknown
- 2001-07-20 AU AU2001270906A patent/AU2001270906B2/en not_active Ceased
- 2001-07-20 CZ CZ20023472A patent/CZ302592B6/cs not_active IP Right Cessation
- 2001-07-20 DE DE60134472T patent/DE60134472D1/de not_active Expired - Lifetime
- 2001-07-20 AT AT01949791T patent/ATE398628T1/de active
- 2001-07-20 ES ES01949791T patent/ES2307628T3/es not_active Expired - Lifetime
- 2001-07-20 EP EP01949791A patent/EP1301526B1/en not_active Expired - Lifetime
- 2001-07-20 US US10/333,537 patent/US20040043974A1/en not_active Abandoned
- 2001-07-20 HU HU0301108A patent/HUP0301108A3/hu unknown
- 2001-07-20 CN CNB018114407A patent/CN1315864C/zh not_active Expired - Fee Related
- 2001-07-20 NZ NZ522083A patent/NZ522083A/en not_active IP Right Cessation
- 2001-07-20 DK DK01949791T patent/DK1301526T3/da active
- 2001-07-20 MX MXPA02010967A patent/MXPA02010967A/es active IP Right Grant
- 2001-07-20 JP JP2002514148A patent/JP2004504403A/ja active Pending
- 2001-07-20 KR KR1020027014367A patent/KR100787293B1/ko not_active Expired - Fee Related
- 2001-07-20 PL PL359462A patent/PL206652B1/pl not_active IP Right Cessation
- 2001-07-20 AU AU7090601A patent/AU7090601A/xx active Pending
- 2001-07-20 HK HK03106680.9A patent/HK1056179B/en not_active IP Right Cessation
- 2001-07-20 IL IL15234801A patent/IL152348A0/xx active IP Right Grant
- 2001-07-20 BR BR0110430-6A patent/BR0110430A/pt not_active Application Discontinuation
- 2001-07-20 SI SI200130851T patent/SI1301526T1/sl unknown
- 2001-07-20 CA CA002406963A patent/CA2406963A1/en not_active Abandoned
-
2002
- 2002-10-17 IL IL152348A patent/IL152348A/en not_active IP Right Cessation
- 2002-10-17 ZA ZA200208372A patent/ZA200208372B/en unknown
- 2002-10-21 NO NO20025054A patent/NO324836B1/no not_active IP Right Cessation
-
2008
- 2008-09-03 CY CY20081100942T patent/CY1108553T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004504403A5 (enExample) | ||
| CA2738543A1 (fr) | Phase precurseur et son utilisation pour preparer le sel de magnesium tetrahydrate d'un enantiomere d'omeprazole | |
| WO2010083722A1 (zh) | 一锅煮方法合成corey内酯的工艺 | |
| JP2010043053A (ja) | 高純度のレバミピドの製造方法 | |
| JP2002544252A5 (enExample) | ||
| JP2010513496A5 (enExample) | ||
| CN116396226A (zh) | 一种替戈拉生及其中间体化合物的制备方法 | |
| JP2003533529A5 (enExample) | ||
| CN112624067A (zh) | 一种双氟磺酰亚胺锂盐的绿色简易的制备方法 | |
| JP2004520308A5 (enExample) | ||
| CN108586375B (zh) | 一种由生物催化氧化环化合成2-取代苯并噁唑化合物的绿色方法 | |
| JP4707976B2 (ja) | ４，４’−ジカルボキシ−２，２’−ビピリジンの製造方法 | |
| EP0192538B1 (fr) | Procédé de préparation de germanate de bismuth de formule Bi4Ge3O12 | |
| JPWO2022086822A5 (enExample) | ||
| JP2003512458A5 (enExample) | ||
| CN121064191A (zh) | 一种奥格列龙半钙盐水合物的制备方法 | |
| CN113754605A (zh) | 一种含氮配体及其制备方法和应用 | |
| CN119059974B (zh) | 一种吡托布鲁替尼的制备方法 | |
| TW200918534A (en) | Racemization process of R-zopiclone | |
| JP2001316397A5 (enExample) | ||
| KR100407720B1 (ko) | Ｎ-[3-｛3-（1-피페리디닐메틸）페녹시｝프로필]아세톡시아세트아미드의 제조방법 | |
| CN118930467A (zh) | 一种亚砜亚胺氟和磺二亚胺氟化合物的电化学合成方法 | |
| JPS6216441A (ja) | １，４−ジクロロブタンの製造法 | |
| KR102242238B1 (ko) | 치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린 화합물, 이의 제조 방법 및 이를 포함하는 2,4 치환된 퀴놀린 화합물 | |
| JP4008671B2 (ja) | ＬｉＢＦ４の製造方法 |